OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
Jabar A. Faraj, Ali Jihad Hemid Al-Athari, Sharaf El Din Mohie, et al.
Medical Oncology (2022) Vol. 39, Iss. 12
Open Access | Times Cited: 11

Showing 11 citing articles:

Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 19

Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7

Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
Man Wang, Lijie Zhu, Xiaoxu Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12

Recent clinical researches and technological development in TIL therapy
Satoko Matsueda, Lei Chen, Hongmei Li, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 4

T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells
Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma
Yuan Shao, Bo Wu, Zhen Yang, et al.
Translational Andrology and Urology (2023) Vol. 12, Iss. 4, pp. 549-571
Open Access | Times Cited: 8

LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy
MAA Mamun, Yu Zhang, Zhao Jin-yuan, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 8

Therapeutic targeting of dormant cancer stem cells in solid tumors
Ghufran Lutfi Ismaeel, Ali Hamid AbdulHussein, Hadeel Qasim, et al.
Gene Reports (2022) Vol. 30, pp. 101717-101717
Closed Access | Times Cited: 7

Long non-coding RNAs: The modulators of innate and adaptive immune cells
Aseel Riyadh Luaibi, Montaha Al-Saffar, Abduladheem Turki Jalil, et al.
Pathology - Research and Practice (2022) Vol. 241, pp. 154295-154295
Open Access | Times Cited: 3

Multicellular Tumoroids for Investigating Cancer Stem-Like Cells in the Heterogeneous Tumor Microenvironment
Kathleen M Burkhard, Geeta Mehta
Methods in molecular biology (2024), pp. 99-122
Closed Access

Salmonella: A bacterial warrior in cancer immunotherapy
Wei Kong, Lingchen Fu, Yixin Shi
Elsevier eBooks (2024), pp. 215-233
Closed Access

Page 1

Scroll to top